insights_auto
Why is LSI up 9.09%?
Dive Deeperchevron_right
LSI:FRA
CK Life Sciences Intl (Holdings) Inc
€0.060
arrow_upward
+9.09%(+0.0050) 1D
Nov 4, 10:00:00 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LSI...
Open
€0.06
High
€0.06
Low
€0.06
Mkt. cap
5.14B
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.11
52-wk low
€0.05
No. of employees
2K
Open
€0.06
High
€0.06
Low
€0.06
Mkt. cap
5.14B
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.11
52-wk low
€0.05
No. of employees
2K
News stories
From web sources and news partners
MarketWatch
·
49 minutes ago
Dow scores its best day in 18 months in a broad relief rally after Democrats sweep to power in Congress
FinancialContent
·
21 minutes ago
Corpay’s (NYSE:CPAY) Q3 2026 sales beat estimates
shattered.io
·
16 minutes ago
S&P Earnings Jump 30.2% as Big Tech Cash Flow Sinks [2026]
Profile
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
About CK Life Sciences Intl (Holdings) Inc
CEOYing Choi Yu
Employees1.92K
Founded2000
Headquarters-
SectorBiotechnology
Industry-
Websiteck-lifesciences.com